Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cellsJinshun Zhu(Huanggang Central Hospital), Lifang Zhang(Ningbo University)Cell Death and DiseaseApril 1, 202010.1038/s41419-020-2410-7Cited by 28SaveCiteExport RISWatch citationsRelated PapersAxl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma|Cells|2024|0